Oral treatment with  improves insulin sensitivity in  mice

Shanthadevi Udayappan; Louise Manneras-Holm; Alice Chaplin-Scott; Clara Belzer; Hilde Herrema; Geesje M Dallinga-Thie; Silvia H Duncan; Erik S G Stroes; Albert K Groen; Harry J Flint; Fredrik Backhed; Willem M de Vos; Max Nieuwdorp

doi:10.1038/npjbiofilms.2016.9

Oral treatment with improves insulin sensitivity in mice

Shanthadevi Udayappan, Louise Manneras-Holm, Alice Chaplin-Scott, Clara Belzer, Hilde Herrema, Geesje M Dallinga-Thie, Silvia H Duncan, Erik S G Stroes, Albert K Groen, Harry J Flint, Fredrik Backhed, Willem M de Vos, Max Nieuwdorp

72 Citationer (Scopus)

80 Downloads (Pure)

Abstract

An altered intestinal microbiota composition is associated with insulin resistance and type 2 diabetes mellitus. We previously identified increased intestinal levels of Eubacterium hallii, an anaerobic bacterium belonging to the butyrate-producing Lachnospiraceae family, in metabolic syndrome subjects who received a faecal transplant from a lean donor. To further assess the effects of E. hallii on insulin sensitivity, we orally treated obese and diabetic db/db mice with alive E. hallii and glycerol or heat-inactive E. hallii as control. Insulin tolerance tests and hyperinsulinemic-euglycemic clamp experiments revealed that alive E. hallii treatment improved insulin sensitivity compared control treatment. In addition, E. hallii treatment increased energy expenditure in db/db mice. Active E. hallii treatment was found to increase faecal butyrate concentrations and to modify bile acid metabolism compared with heat-inactivated controls. Our data suggest that E. hallii administration potentially alters the function of the intestinal microbiome and that microbial metabolites may contribute to the improved metabolic phenotype.

Originalsprog	Engelsk
Artikelnummer	16009
Tidsskrift	npj Biofilms and Microbiomes
Vol/bind	2
Antal sider	10
ISSN	2055-5008
DOI	https://doi.org/10.1038/npjbiofilms.2016.9
Status	Udgivet - 2016

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1038/npjbiofilms.2016.9Licens: CC BY

Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db miceForlagets udgivne version, 1,2 MBLicens: CC BY

Citationsformater

@article{e71064337f114a0eafd44d3c17f3a2d3,

title = "Oral treatment with improves insulin sensitivity in mice",

abstract = "An altered intestinal microbiota composition is associated with insulin resistance and type 2 diabetes mellitus. We previously identified increased intestinal levels of Eubacterium hallii, an anaerobic bacterium belonging to the butyrate-producing Lachnospiraceae family, in metabolic syndrome subjects who received a faecal transplant from a lean donor. To further assess the effects of E. hallii on insulin sensitivity, we orally treated obese and diabetic db/db mice with alive E. hallii and glycerol or heat-inactive E. hallii as control. Insulin tolerance tests and hyperinsulinemic-euglycemic clamp experiments revealed that alive E. hallii treatment improved insulin sensitivity compared control treatment. In addition, E. hallii treatment increased energy expenditure in db/db mice. Active E. hallii treatment was found to increase faecal butyrate concentrations and to modify bile acid metabolism compared with heat-inactivated controls. Our data suggest that E. hallii administration potentially alters the function of the intestinal microbiome and that microbial metabolites may contribute to the improved metabolic phenotype.",

author = "Shanthadevi Udayappan and Louise Manneras-Holm and Alice Chaplin-Scott and Clara Belzer and Hilde Herrema and Dallinga-Thie, {Geesje M} and Duncan, {Silvia H} and Stroes, {Erik S G} and Groen, {Albert K} and Flint, {Harry J} and Fredrik Backhed and {de Vos}, {Willem M} and Max Nieuwdorp",

year = "2016",

doi = "10.1038/npjbiofilms.2016.9",

language = "English",

volume = "2",

journal = "npj Biofilms and Microbiomes",

issn = "2055-5008",

publisher = "nature publishing group",

}

TY - JOUR

T1 - Oral treatment with improves insulin sensitivity in mice

AU - Udayappan, Shanthadevi

AU - Manneras-Holm, Louise

AU - Chaplin-Scott, Alice

AU - Belzer, Clara

AU - Herrema, Hilde

AU - Dallinga-Thie, Geesje M

AU - Duncan, Silvia H

AU - Stroes, Erik S G

AU - Groen, Albert K

AU - Flint, Harry J

AU - Backhed, Fredrik

AU - de Vos, Willem M

AU - Nieuwdorp, Max

PY - 2016

Y1 - 2016

N2 - An altered intestinal microbiota composition is associated with insulin resistance and type 2 diabetes mellitus. We previously identified increased intestinal levels of Eubacterium hallii, an anaerobic bacterium belonging to the butyrate-producing Lachnospiraceae family, in metabolic syndrome subjects who received a faecal transplant from a lean donor. To further assess the effects of E. hallii on insulin sensitivity, we orally treated obese and diabetic db/db mice with alive E. hallii and glycerol or heat-inactive E. hallii as control. Insulin tolerance tests and hyperinsulinemic-euglycemic clamp experiments revealed that alive E. hallii treatment improved insulin sensitivity compared control treatment. In addition, E. hallii treatment increased energy expenditure in db/db mice. Active E. hallii treatment was found to increase faecal butyrate concentrations and to modify bile acid metabolism compared with heat-inactivated controls. Our data suggest that E. hallii administration potentially alters the function of the intestinal microbiome and that microbial metabolites may contribute to the improved metabolic phenotype.

AB - An altered intestinal microbiota composition is associated with insulin resistance and type 2 diabetes mellitus. We previously identified increased intestinal levels of Eubacterium hallii, an anaerobic bacterium belonging to the butyrate-producing Lachnospiraceae family, in metabolic syndrome subjects who received a faecal transplant from a lean donor. To further assess the effects of E. hallii on insulin sensitivity, we orally treated obese and diabetic db/db mice with alive E. hallii and glycerol or heat-inactive E. hallii as control. Insulin tolerance tests and hyperinsulinemic-euglycemic clamp experiments revealed that alive E. hallii treatment improved insulin sensitivity compared control treatment. In addition, E. hallii treatment increased energy expenditure in db/db mice. Active E. hallii treatment was found to increase faecal butyrate concentrations and to modify bile acid metabolism compared with heat-inactivated controls. Our data suggest that E. hallii administration potentially alters the function of the intestinal microbiome and that microbial metabolites may contribute to the improved metabolic phenotype.

U2 - 10.1038/npjbiofilms.2016.9

DO - 10.1038/npjbiofilms.2016.9

M3 - Journal article

C2 - 28721246

SN - 2055-5008

VL - 2

JO - npj Biofilms and Microbiomes

JF - npj Biofilms and Microbiomes

M1 - 16009

ER -

Oral treatment with improves insulin sensitivity in mice

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater